Suzanne Topalian reports a stock award at Vir Biotechnology
By AlphaYouPublished Form 4
Topalian Suzanne Louise
Reporting filer
Suzanne Louise Topalian reports a stock award, not an open-market purchase or sale, in Vir Biotechnology, Inc.. Form 4 filed Oct 28, 2026 lists 4 entries.
- Disclosed
- Oct 28, 2026
Reported details
4 entries| Security | Owner | Date | Code | Action | Quantity | Price | Following holdings | Reporting delay | Filed terms and references |
|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Topalian Suzanne Louise | 2026-10-27 | A | Grant or award | 8000 | 0 | 8,000 | 1 day | Filed terms
|
| Common Stock | Topalian Suzanne Louise | 2026-10-27 | A | Grant or award | 4731 | 0 | 12,731 | 1 day | Filed terms
|
| Stock Option (Right to Buy) (derivative) | Topalian Suzanne Louise | 2026-10-27 | A | Grant or award | 16000 | 0 | 16,000 | 1 day | Filed terms
|
| Stock Option (Right to Buy) (derivative) | Topalian Suzanne Louise | 2026-10-27 | A | Grant or award | 9462 | 0 | 25,462 | 1 day | Filed terms
|
Common Stock
- Owner
- Topalian Suzanne Louise
- Date
- 2026-10-27
- Code
- A
- Action
- Grant or award
- Quantity
- 8000
- Price
- 0
- Following holdings
- 8,000
- Reporting delay
- 1 day
- Filed terms and references
Filed terms
- security Title: Common Stock
- transaction Date: 2026-10-27
- transaction Form Type: 4
- transaction Code: A
- equity Swap Involved: 0
- id: F1
- transaction Shares: 8000
- id: F2
- transaction Price Per Share: 0
- transaction Acquired Disposed Code: A
- shares Owned Following Transaction: 8000
- direct Or Indirect Ownership: D
Common Stock
- Owner
- Topalian Suzanne Louise
- Date
- 2026-10-27
- Code
- A
- Action
- Grant or award
- Quantity
- 4731
- Price
- 0
- Following holdings
- 12,731
- Reporting delay
- 1 day
- Filed terms and references
Filed terms
- security Title: Common Stock
- transaction Date: 2026-10-27
- transaction Form Type: 4
- transaction Code: A
- equity Swap Involved: 0
- id: F1
- transaction Shares: 4731
- id: F3
- transaction Price Per Share: 0
- transaction Acquired Disposed Code: A
- shares Owned Following Transaction: 12731
- direct Or Indirect Ownership: D
Stock Option (Right to Buy) (derivative)
- Owner
- Topalian Suzanne Louise
- Date
- 2026-10-27
- Code
- A
- Action
- Grant or award
- Quantity
- 16000
- Price
- 0
- Following holdings
- 16,000
- Reporting delay
- 1 day
- Filed terms and references
Filed terms
- security Title: Stock Option (Right to Buy)
- conversion Or Exercise Price: 11.57
- transaction Date: 2026-10-27
- transaction Form Type: 4
- transaction Code: A
- equity Swap Involved: 0
- transaction Shares: 16000
- transaction Price Per Share: 0
- transaction Acquired Disposed Code: A
- id: F4
- expiration Date: 2036-10-26
- underlying Security Title: Common Stock
- underlying Security Shares: 16000
- shares Owned Following Transaction: 16000
- direct Or Indirect Ownership: D
Stock Option (Right to Buy) (derivative)
- Owner
- Topalian Suzanne Louise
- Date
- 2026-10-27
- Code
- A
- Action
- Grant or award
- Quantity
- 9462
- Price
- 0
- Following holdings
- 25,462
- Reporting delay
- 1 day
- Filed terms and references
Filed terms
- security Title: Stock Option (Right to Buy)
- conversion Or Exercise Price: 11.57
- transaction Date: 2026-10-27
- transaction Form Type: 4
- transaction Code: A
- equity Swap Involved: 0
- transaction Shares: 9462
- transaction Price Per Share: 0
- transaction Acquired Disposed Code: A
- id: F5
- expiration Date: 2036-10-26
- underlying Security Title: Common Stock
- underlying Security Shares: 9462
- shares Owned Following Transaction: 25462
- direct Or Indirect Ownership: D
Purchases, sales, grants and option exercises are different transactions. The reported code identifies the action; it does not establish a motive.
Filing context
- Quantities and prices are shown in the units filed. No trade value is inferred from their product.
- Topalian Suzanne Louise: Director.
- F1: Acquisition of restricted stock units (RSUs) pursuant to the Issuer's Equity Incentive Plan.
- F2: 1/3 of the RSUs will vest on October 27, 2027, and the remaining RSUs will vest in two equal annual installments thereafter.
- F3: The RSUs will vest in full on the earlier of (i) October 27, 2027, or (ii) the date of the Issuer's next annual meeting of stockholders.
- F4: 1/3 of the shares subject to the stock option will vest and become exercisable on October 27, 2027, and the remaining shares will vest and become exercisable in 24 equal monthly installments thereafter.
- F5: The shares subject to the stock option vest and become exercisable in full on the earlier of (i) October 27, 2027, or (ii) the date of the Issuer's next annual meeting of stockholders.
Original sources
Prepared automatically from public filing data. Report a correction.